| Jason Hamlin is the founder of Nicoya Research and has published investment research for over a decade. He previously worked in data analytics for Nielsen, the world’s largest market research firm, where he consulted to Fortune 500 companies including Nestlé, Johnson & Johnson and Del Monte. Jason eventually left the corporate world and leveraged his analytical skills to successfully trade stocks full-time while traveling the world. After helping his parents 5x their investment portfolio in under two years, Jason decided to start Nicoya Research and share his investment research and strategies to help other people find success and financial freedom. | 
Cannabis stocks have been spiking higher over the past few weeks amid reports that the US government is moving to reclassify marijuana to a much lower risk category under the Controlled Substances Act. Bloomberg reported that the US Department of Health and Human Services had sent a letter to the US Drug Enforcement Administration recommending […]
